March 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountorserduhcp.com
Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
88.31%
Pages per Visit
1.12
Avg Visit Duration
00:00:11
- Company
- - -
- Industry
- - -
Top 10 orserduhcp.com Competitors
The Top 10 Sites Like orserduhcp.com in March 2026 are ranked by their affinity to orserduhcp.com in terms of keyword traffic, audience targeting, and market overlap
Evaluate ORSERDU®, a treatment option for ESR1-mutated, ER+/HER2- advanced or metastatic breast cancer following disease progression on endocrine therapy.
- Company
- - -
- Industry
- - -
Bounce Rate
83.56%
Pages per Visit
1.29
Avg Visit Duration
00:00:19
Similarity Score
100%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
53.59%
Pages per Visit
1.34
Avg Visit Duration
00:00:17
Similarity Score
87%Find a list of questions to start a conversation with your doctor about POLIVY® (polatuzumab vedotin-piiq) plus R-CHP and DLBCL. See full safety information.
- Company
- - -
- Industry
- - -
Bounce Rate
91.36%
Pages per Visit
1.25
Avg Visit Duration
00:00:02
Similarity Score
82%Find useful advanced BCC resources and tools for both patients and caregivers. Review Important Safety Info & Full Prescribing Information including Med Guide.
- Company
- - -
- Industry
- - -
Global Rank
#496,309
16,324Bounce Rate
86.63%
Pages per Visit
1.27
Avg Visit Duration
00:00:25
Similarity Score
80%- Company
- - -
- Industry
- - -
Bounce Rate
83.77%
Pages per Visit
1.34
Avg Visit Duration
00:00:24
Similarity Score
79%ELAHERE for patients. Learn more about ELAHERE® (mirvetuximab soravtansine-gynx) for injection, a prescription medicine. Please see Full Prescribing Information, including BOXED WARNING and Medication Guide.
- Company
- - -
- Industry
- - -
Bounce Rate
95.26%
Pages per Visit
1.11
Avg Visit Duration
00:00:05
Similarity Score
78%Review frequently asked questions and answers about NUBEQA® (darolutamide). See safety and full prescribing info.
- Company
- - -
- Industry
- - -
Global Rank
#707,128
256,421Bounce Rate
73.97%
Pages per Visit
1.27
Avg Visit Duration
00:01:05
Similarity Score
77%Review answers to common questions about gastrointestinal stromal tumor and how AYVAKIT treats PDGFRA GIST. See ISI and PI for more information.
- Company
- - -
- Industry
- - -
Global Rank
#1,476,564
374,145Bounce Rate
80.75%
Pages per Visit
1.21
Avg Visit Duration
00:01:33
Similarity Score
76%Find National Comprehensive Cancer Network regimen recommendations for PADCEV® for la/mUC. Please see Important Safety and Prescribing Information, including BOXED WARNING.
- Company
- - -
- Industry
- - -
Bounce Rate
79.83%
Pages per Visit
1.32
Avg Visit Duration
00:00:58
Similarity Score
75%This dual binding process activates T cells to target and destroy myeloma cells with BCMA on their surface. It may also harm a type of ...
- Company
- - -
- Industry
- - -
Bounce Rate
62.9%
Pages per Visit
1.61
Avg Visit Duration
00:02:09
Similarity Score
74%orserduhcp.com's top 5 competitors in March 2026 are: orserdu.com, verzenio.lilly.com, polivy.com, libtayo.com, and more.
According to Similarweb data of monthly visits, orserduhcp.com’s top competitor in March 2026 is orserdu.com. orserduhcp.com 2nd most similar site is verzenio.lilly.com, and closing off the top 3 is polivy.com.
libtayo.com ranks as the 4th most similar website to orserduhcp.com and ibtrozi.com ranks fifth in March 2026.
The other five competitors in the top 10 list are elahere.com, nubeqa-us.com, ayvakit.com, padcevhcp.com, and elrexfio.com.